Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 13/20 | 0.48 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2213705 | 0.96 | MAPK14 (0.52) | MAPK14MAPK11CYP3A4CYP2C9RIPK2 | |
| SCHEMBL2215786 | 0.93 | CYP3A4 (0.51) | MAPK14MAPK11CYP3A4CYP2C9RIPK2 | |
| SCHEMBL2216809 | 0.93 | CYP3A4 (0.52) | MAPK14MAPK11CYP3A4CYP2C9 | |
| SCHEMBL2214411 | 0.90 | MAPK14 (0.46) | MAPK14MAPK11CYP3A4CYP2C9RIPK2 | |
| SCHEMBL2214153 | 0.88 | MAPK14 (0.45) | MAPK14MAPK11CYP3A4CYP2C9RIPK2 | |
| SCHEMBL2218133 | 0.86 | MAPK14 (0.54) | MAPK14MAPK11 | |
| SCHEMBL2215757 | 0.85 | MAPK14 (0.46) | MAPK14MAPK11CYP3A4CYP2C9 | |
| SCHEMBL2213883 | 0.85 | MAPK14 (0.47) | MAPK14MAPK11CYP3A4CYP2C9 | |
| SCHEMBL1384571 | 0.85 | MAPK14 (0.61) | MAPK14MAPK11TP53POLBCYP3A4 | |
| SCHEMBL2212193 | 0.85 | MAPK14 (0.44) | MAPK14MAPK11CYP3A4CYP2C9RIPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1641764-B1 | 5-MEMBERED HETEROCYCLE-BASED P38 KINASE INHIBITORS | NOVARTIS AG (CH) | 2011-07-27 | — | — | EP | claimed |